Bayer is launching a new fludioxonil seed treatment in Canada, set to be available in 2026.

Raxil has always been the number one grain seed treatment brand in Western Canada, and the launch of Raxil Rise is based on the 25-year track record of the Raxil brand. The main features of Raxil Rise are as follows: · Enhanced broad-spectrum disease control: Raxil Rise, through the addition of fludioxonil, significantly enhances the protection against various yield-reducing diseases, such as Fusarium head blight and diseases caused by Fusarium. · Micro-dispersion formula with excellent coverage: The product uses a micro-dispersion formula, ensuring excellent seed coverage, outstanding flowability at different temperatures, and low dust drift. Additionally, Raxil Rise incorporates a richly colored dye, allowing farmers to visually see the coverage effect. · Synergistic action of four active ingredients: Raxil Rise contains four fungicidal active ingredients, including fludioxonil, tebuconazole, propiconazole, and carbendazim, providing comprehensive contact and systemic disease ...